30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Akamine Scott

Track

Insider profile

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Akamine Scott's trades of Cerevel Therapeutics Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-21 2023-12-20
S Sale
82,971 -23.3%
195.42
US$3,309,114 		82,971 -23.3% 195.42 US$3,309,114
2023-12-07 2023-12-07
PrS Proposed sale
18,300
55.20
US$596,430 		18,300 55.20 US$596,430
2023-12-07 2023-12-07
PlS Planned sale
62,470 -35.6%
235.46
US$4,247,277 		62,470 -35.6% 235.46 US$4,247,277
2023-12-07 2023-12-05
PlS Planned sale
7,500 -93.6%
35.00
US$262,500 		7,500 -93.6% 35.00 US$262,500
2023-12-05 2023-12-05
PrS Proposed sale
7,500
35.00
US$262,500 		7,500 35.00 US$262,500
2022-08-09 2022-08-08
PlS Planned sale
10,000 -100.0%
40.00
US$400,001 		10,000 -100.0% 40.00 US$400,001